Tesidolumab (LFG316, 1531594-08-7): A Research Tool for Immunological Studies
Tesidolumab, also known as LFG316, specified by the CAS number 1531594-08-7, represents a valuable research tool for furthering host defense investigations. The protein primarily targets a specific receptor linked to immune mediated responses, allowing it to be used employed to investigate the nature of body response. Scientists use the molecule to gain insights into illness occurrence and to uncover new therapeutic strategies. Its availability as a substance facilitates extensive analysis within laboratory and living organism settings.
```
```text
Investigating Tesidolumab (LFG316) in Research Applications
Researchers are progressively exploring the potential utility of tesidolumab (LFG316) in a variety of laboratory settings . Early data suggest it appears offer valuable perspectives into biological processes involved in allergic disorders. Specifically, current work revolve on assessing its impact on immune cell response and protein production , with the goal of discovering novel biological markers and possibly advancing future therapeutic methodologies .
```
Tesidolumab LFG316: Examining Future Investigation Pathways
More study into the drug LFG316 provides promising possibilities for ongoing analysis. Key areas of focus could cover:
- Evaluating its potency in various subject cohorts, particularly those experiencing intense inflammatory ailments.
- Establishing the specific mode of function and its influence on physiological functions.
- Determining potential signals that anticipate therapeutic response and enable for personalized treatment.
- Evaluating the sustained security profile and detecting any anticipated adverse outcomes.
Research Grade Tesidolumab (1531594-08-7) – Specifications and Functionality
Tesidolumab, identified by the identifier 1531594-08-7, is a research grade molecule currently being studied for its therapeutic potential in autoimmune disorders. Exceptional quality is guaranteed through rigorous validation processes, resulting in a product typically demonstrating a purity of ≥95% as assessed by analytical methods. Typical preparations are available as a sterile, lyophilized powder, requiring reconstitution with a suitable buffer. Potential applications for this protein include, but are not limited to, experimental research focused on inflammatory pathways. Further information regarding specific details can be accessed through the accompanying literature.
- MW : Approximately 145 kDa
- Storage Conditions : -20°C or lower
- Suggested Buffer: PBS
The Compound for Research : Access and Handling
Accessing LFG316 for research requires careful planning and adherence to strict procedures. Currently, the drug is generally available through specialized biological resource centers , often via a limited distribution program. Securing typically involves a detailed request process specifying the intended study design. Handling this compound demands expertise; it's usually supplied in a cryopreserved form requiring specialized equipment for thawing and maintenance.
- Careful temperature control is imperative.
- Appropriate personal safety gear must be employed .
- Byproduct removal should follow designated institutional policies .
```text
Revealing Insights with the Compound: A Scientific Substance (1531594-08-7)
Scientists utilizing Tesidolumab (1531594-08-7), a critical research tool, are here beginning to discover important insights into intricate cellular processes. This molecule offers a specific opportunity for studying disorder courses and promising medical goals. More experiments using Tesidolumab promise to yield important improvements in the domain of biological science.
```